Pipeline Watch: Phase III Progress With Erenumab, Sirukumab And Sarilumab

21 Nov 2016

• By John Davis

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between November 11 and November 17, 2016, divided by event type.

Events can include Phase II and Phase III trial initiations, development discontinuations, and the release of top-line and full clinical...